| scholarly article | Q13442814 |
| P2093 | author name string | Zvi Granot | |
| Steven M Albelda | |||
| Zvi G Fridlender | |||
| Evgeniy Eruslanov | |||
| Sunil Singhal | |||
| Inbal Mishalian | |||
| Liran Levy | |||
| Janna Michaeli | |||
| Lida Zolotarov | |||
| Rachel Bayuh | |||
| P2860 | cites work | Suppression, subversion and escape: the role of regulatory T cells in cancer progression | Q27026151 |
| Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival | Q29547865 | ||
| Polarization of tumor-associated neutrophil phenotype by TGF-beta: "N1" versus "N2" TAN | Q29619346 | ||
| Neutrophils in the activation and regulation of innate and adaptive immunity | Q29620082 | ||
| Depletion of regulatory T cells by anti-GITR mAb as a novel mechanism for cancer immunotherapy | Q34116065 | ||
| Transcriptomic analysis comparing tumor-associated neutrophils with granulocytic myeloid-derived suppressor cells and normal neutrophils | Q34163579 | ||
| Monocyte chemoattractant protein-1 blockade inhibits lung cancer tumor growth by altering macrophage phenotype and activating CD8+ cells | Q34626551 | ||
| Infiltrating neutrophils mediate the initial angiogenic switch in a mouse model of multistage carcinogenesis | Q34928194 | ||
| Chemokines as therapeutic targets in non-small cell lung cancer | Q35100511 | ||
| Intratumoral CD4+CD25+ regulatory T-cell-mediated suppression of infiltrating CD4+ T cells in B-cell non-Hodgkin lymphoma | Q35849633 | ||
| Comprehensive analysis of current approaches to inhibit regulatory T cells in cancer | Q36057441 | ||
| Evasion of myofibroblasts from immune surveillance: a mechanism for tissue fibrosis | Q36300021 | ||
| Inhibition of tumor growth by elimination of granulocytes | Q36364220 | ||
| The metastasis-promoting roles of tumor-associated immune cells | Q36972016 | ||
| The role of chemokines in neutrophil biology | Q36992462 | ||
| Systemic blockade of transforming growth factor-beta signaling augments the efficacy of immunogene therapy | Q37087603 | ||
| Inhibition of p300 impairs Foxp3⁺ T regulatory cell function and promotes antitumor immunity. | Q37222190 | ||
| T regulatory cells and their counterparts: masters of immune regulation | Q37473347 | ||
| Tumor-associated neutrophils: new targets for cancer therapy | Q37856086 | ||
| On the dual roles and polarized phenotypes of neutrophils in tumor development and progression. | Q37907594 | ||
| Tumor-associated neutrophils: friend or foe? | Q37994480 | ||
| Regulatory T cells in human ovarian cancer | Q38000557 | ||
| T-regulatory cells: key players in tumor immune escape and angiogenesis | Q38006901 | ||
| Tumor-associated neutrophils (TAN) develop pro-tumorigenic properties during tumor progression | Q39087629 | ||
| Dissociation of endotoxin tolerance and differentiation of alternatively activated macrophages | Q39173180 | ||
| Small cell lung cancer tumour cells induce regulatory T lymphocytes, and patient survival correlates negatively with FOXP3+ cells in tumour infiltrate | Q39359136 | ||
| Differential regulation of thymus- and activation-regulated chemokine induced by IL-4, IL-13, TNF-alpha and IFN-gamma in human keratinocyte and fibroblast | Q40700841 | ||
| Innate immune recognition of breast tumor cells mediates CCL22 secretion favoring Treg recruitment within tumor environment. | Q42321650 | ||
| Unique chemotactic response profile and specific expression of chemokine receptors CCR4 and CCR8 by CD4(+)CD25(+) regulatory T cells | Q42947524 | ||
| Lung adenocarcinoma invasion in TGFbetaRII-deficient cells is mediated by CCL5/RANTES. | Q42949508 | ||
| Hepatitis C virus induces the expression of CCL17 and CCL22 chemokines that attract regulatory T cells to the site of infection. | Q43031638 | ||
| Human CD4+ FOXP3+ regulatory T cells produce CXCL8 and recruit neutrophils | Q46959827 | ||
| Evidence for a cross-talk between human neutrophils and Th17 cells | Q58883553 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1178-1186 | |
| P577 | publication date | 2014-02-27 | |
| P1433 | published in | International Journal of Cancer | Q332492 |
| P1476 | title | Neutrophils recruit regulatory T-cells into tumors via secretion of CCL17--a new mechanism of impaired antitumor immunity | |
| P478 | volume | 135 |
| Q91862764 | A correlation-based network for biomarker discovery in obesity with metabolic syndrome |
| Q49482085 | Anti-tumour effects of polysaccharide extracted from Acanthopanax senticosus and cell-mediated immunity |
| Q89526161 | Characterization of the immune microenvironment in brain metastases from different solid tumors |
| Q93047625 | Context Drives Diversification of Monocytes and Neutrophils in Orchestrating the Tumor Microenvironment |
| Q34558889 | Core needle biopsy of breast cancer tumors increases distant metastases in a mouse model. |
| Q58763382 | Cxcr1 mediates recruitment of neutrophils and supports proliferation of tumor-initiating astrocytes in vivo |
| Q47139132 | Development of A Chimeric Antigen Receptor Targeting C-Type Lectin-Like Molecule-1 for Human Acute Myeloid Leukemia |
| Q57817490 | Diamonds in the Rough: Harnessing Tumor-Associated Myeloid Cells for Cancer Therapy |
| Q39107166 | Epithelial Hypoxia-Inducible Factor 2α Facilitates the Progression of Colon Tumors through Recruiting Neutrophils |
| Q41921212 | Genomic Programming of Human Neonatal Dendritic Cells in Congenital Systemic and In Vitro Cytomegalovirus Infection Reveal Plastic and Robust Immune Pathway Biology Responses |
| Q35549911 | Granulocytic immune infiltrates are essential for the efficient formation of breast cancer liver metastases |
| Q36140620 | Hematopoietic cell kinase (HCK) as a therapeutic target in immune and cancer cells. |
| Q92959489 | Hypoxic Regulation of Neutrophils in Cancer |
| Q92228710 | IL4Rα Signaling Abrogates Hypoxic Neutrophil Survival and Limits Acute Lung Injury Responses In Vivo |
| Q99411650 | IRF1-mediated immune cell infiltration is associated with metastasis in colon adenocarcinoma |
| Q38951790 | Lymphocyte-mediated Immune Regulation in Health and Disease: The Treg and γδ T Cell Co-conspiracy |
| Q56942176 | Macrophages, Neutrophils, and Cancer: A Double Edged Sword |
| Q38811948 | MicroRNA-31 is a positive modulator of endothelial-mesenchymal transition and associated secretory phenotype induced by TGF-β. |
| Q64237914 | Neutrophil trafficking to lymphoid tissues: physiological and pathological implications |
| Q38827101 | Neutrophil-derived chemokines on the road to immunity |
| Q38265504 | Neutrophil-derived cytokines: facts beyond expression |
| Q92968545 | Neutrophil-to-lymphocyte ratio as prognostic marker in esophageal cancer: a systematic review and meta-analysis |
| Q92405284 | Neutrophils as a Therapeutic Target in Cancer |
| Q26773072 | Neutrophils in Cancer: Two Sides of the Same Coin |
| Q89613135 | Neutrophils in the Tumor Microenvironment |
| Q35149564 | Neutrophils with protumor potential could efficiently suppress tumor growth after cytokine priming and in presence of normal NK cells |
| Q89639938 | Novel lymphocyte to red blood cell ratio (LRR), neutrophil to red blood cell ratio (NRR), monocyte to red blood cell ratio (MRR) as predictive and prognostic biomarkers for locally advanced breast cancer |
| Q54935837 | PD-L1 expression in colorectal cancer defines three subsets of tumor immune microenvironments. |
| Q47437633 | Phagocyte-extracellular matrix crosstalk empowers tumor development and dissemination |
| Q39173529 | Phenotype and function of tumor-associated neutrophils and their subsets in early-stage human lung cancer. |
| Q35823802 | Promoting metastasis: neutrophils and T cells join forces |
| Q55008935 | Serine Proteases Enhance Immunogenic Antigen Presentation on Lung Cancer Cells. |
| Q89861814 | Technical Considerations in Ex Vivo Human Regulatory T Cell Migration and Suppression Assays |
| Q28075994 | The CXCL8-CXCR1/2 pathways in cancer |
| Q39000116 | The Diverse Biological Functions of Neutrophils, Beyond the Defense Against Infections |
| Q39076005 | The Essential Role of Type I Interferons in Differentiation and Activation of Tumor-Associated Neutrophils |
| Q26746986 | The IL-8/IL-8R Axis: A Double Agent in Tumor Immune Resistance |
| Q26824147 | The cancer stem cell niche: how essential is the niche in regulating stemness of tumor cells? |
| Q49265524 | The regulation of pre-metastatic niche formation by neutrophils |
| Q64464492 | The role of neutrophils in cancer |
| Q26766429 | Tumor-Associated Macrophages and Neutrophils in Tumor Microenvironment |
| Q90208049 | Tumor-Associated Neutrophils in Cancer: Going Pro |
| Q39079703 | Tumor-associated neutrophils display a distinct N1 profile following TGFβ modulation: A transcriptomics analysis of pro- vs. antitumor TANs |
| Q50424573 | Tumor-associated neutrophils induce apoptosis of non-activated CD8 T-cells in a TNFα and NO-dependent mechanism, promoting a tumor-supportive environment |
| Q57183696 | Tumor-derived exosomes induce N2 polarization of neutrophils to promote gastric cancer cell migration |
| Q92502928 | Tumour-associated neutrophils in patients with cancer |
| Q47621546 | Tumour-infiltrating inflammatory and immune cells in patients with extrahepatic cholangiocarcinoma |
| Q89653483 | Unfolding innate mechanisms in the cancer microenvironment: The emerging role of the mesenchyme |
Search more.